摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-5-methyl-1-<4-(hydroxymethyl)-3-cyclopentenyl>-2,4(1H,3H)-pyrimidinedione | 161168-72-5

中文名称
——
中文别名
——
英文名称
(+/-)-5-methyl-1-<4-(hydroxymethyl)-3-cyclopentenyl>-2,4(1H,3H)-pyrimidinedione
英文别名
(+/-)-1-[3-(Hydroxymethyl)cyclopent-3-en-1-yl]-5-methylpyrimidine-2(1H),4(3H)-dione;(+/-)-1-[4-(hydroxymethyl)cyclopent-3-en-1-yl]thymine;1-[3-(Hydroxymethyl)cyclopent-3-en-1-yl]-5-methylpyrimidine-2,4-dione
(+/-)-5-methyl-1-<4-(hydroxymethyl)-3-cyclopentenyl>-2,4(1H,3H)-pyrimidinedione化学式
CAS
161168-72-5
化学式
C11H14N2O3
mdl
——
分子量
222.244
InChiKey
UVVCEOFVULZRIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    69.6
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • A New and Short Convergent Synthetic Strategy to Carbocyclic Nucleosides
    作者:Bastian Reichardt、Chris Meier
    DOI:10.1080/15257770701507937
    日期:2007.11.26
    An efficient synthesis for racemic cyclopent-3-en-1-yl nucleoside analogues has been developed starting from cyclopentadiene. The key step is the regioselective hydroboration of a mixture of intermediate alkylatede cyclopentadienes to give one cyclopentenol.
    外消旋环戊-3-烯-1-基核苷类似物的有效合成已从环戊二烯开始。关键步骤是中间体烷基化环戊二烯混合物的区域选择性氢化反应得到一种环戊烯醇。
  • Synthesis of Carbocyclic 4'-C-Hydroxymethyl Analogues of Azidodeoxythymidine, Deoxythymidine, Deoxydidehydrothymidine and Thymidine Carba Analogue with Fused Oxetane Ring
    作者:Hubert Hřebabecký、Antonín Holý
    DOI:10.1135/cccc20000395
    日期:——

    Tosylation of (±)-1-[trans-4-hydroxy-3,3-bis(hydroxymethyl)cyclopentyl]-5-methylpyrimidine-2(1H),4(3H)-dione (1) and (±)-1-[cis-4-hydroxy-3,3-bis(hydroxymethyl)cyclopentyl]-5-methylpyrimidine-2(1H),4(3H)-dione (2) and treatment of the obtained 1-(1R*,3R*,4S*)- 4-hydroxy-3-(hydroxymethyl)-3-[(tosyloxy)methyl]cyclopentyl}-5-methylpyrimidine- 2(1H),4(3H)-dione (6) and 1-(1R*,3S*,4R*)-4-hydroxy-3-(hydroxymethyl)-3-[(tosyloxy)- methyl]cyclopentyl}-5-methylpyrimidine-2(1H),4(3H)-dione (9) with methanolic sodium methoxide gave 1-[(1R*,4S*,6S*)-4-hydroxymethyl-2-oxabicyclo[3.2.0]hept-6-yl]-5-methylpyrimidine-2(1H),4(3H)-dione (7) and 1-[(1R*,4S*,6R*)-4-hydroxymethyl-2-oxabicyclo[3.2.0]hept-6-yl]-5-methylpyrimidine-2(1H),4(3H)-dione (10), respectively. Treatment of (±)-1-cis-4-mesyloxy-3,3-bis[(trityloxy)methyl]cyclopentyl}-5-methylpyrimidine-2(1H),4(3H)-dione (11), which was prepared from 2 by tritylation and mesylation, with 1,8-diazabicyclo[5.4.0]undec-7-ene in dimethylformamide afforded after deprotection (±)-1-[4,4-bis(hydroxymethyl)cyclopent-2-en-1-yl]-5-methylpyrimidine-2(1H),4(3H)-dione (14). Hydrogen- ation of 14 led to (±)-1-[3,3-bis(hydroxymethyl)cyclopentyl]-5-methylpyrimidine-2(1H),4(3H)- dione (15). (±)-1-trans-4-Mesyloxy-3,3-bis[(trityloxy)methyl]cyclopentyl}-5-methylpyrimidine- 2(1H),4(3H)-dione (17), which was prepared from 1, was converted to (1R*,9R*)-6-methyl-5-oxo-11,11-bis(trityloxymethyl)-2-oxa-4,8-diazatricyclo[7.2.1.03,8]dodec-3,6-diene (18). The compound 18 was deprotected and heated with lithium azide in dimethylformamide to give (±)-1-[trans-4-azido-3,3-bis(hydroxymethyl)cyclopentyl]-5-methylpyrimidine-2(1H),4(3H)-dione (21).

    对(±)-1-[trans-4-羟基-3,3-双(羟甲基)环戊基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (1)和(±)-1-[cis-4-羟基-3,3-双(羟甲基)环戊基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (2)进行甲苯磺酸化反应,得到1-(1R*,3R*,4S*)-4-羟基-3-(羟甲基)-3-[(对甲苯磺酰氧)甲基]环戊基}-5-甲基嘧啶-2(1H),4(3H)-二酮 (6)和1-(1R*,3S*,4R*)-4-羟基-3-(羟甲基)-3-[(对甲苯磺酰氧)甲基]环戊基}-5-甲基嘧啶-2(1H),4(3H)-二酮 (9)。将得到的化合物与甲醇钠甲醇溶液反应,得到1-[(1R*,4S*,6S*)-4-羟甲基-2-氧杂双环[3.2.0]庚-6-基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (7)和1-[(1R*,4S*,6R*)-4-羟甲基-2-氧杂双环[3.2.0]庚-6-基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (10)。将(±)-1-cis-4-甲磺氧基-3,3-双[(三苯甲氧基)甲基]环戊基}-5-甲基嘧啶-2(1H),4(3H)-二酮 (11)与1,8-二氮杂双环[5.4.0]十一碳-7-烯在二甲基甲酰胺中反应,去保护后得到(±)-1-[4,4-双(羟甲基)环戊-2-烯基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (14)。对14进行氢化反应,得到(±)-1-[3,3-双(羟甲基)环戊基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (15)。从1制备(±)-1-trans-4-甲磺氧基-3,3-双[(三苯甲氧基)甲基]环戊基}-5-甲基嘧啶-2(1H),4(3H)-二酮 (17),并将其转化为(1R*,9R*)-6-甲基-5-氧代-11,11-双(三苯甲氧基甲基)-2-氧杂四环[7.2.1.03,8]十二碳-3,6-二烯 (18)。将化合物18去保护并在二甲基甲酰胺中与叠氮化合物加热反应,得到(±)-1-[trans-4-叠氮基-3,3-双(羟甲基)环戊基]-5-甲基嘧啶-2(1H),4(3H)-二酮 (21)。
  • Carbocyclic Analogues of 3′,4′-Didehydro-2′-deoxyribofuranosyl-2,4(1<i>H</i>,3<i>H</i>)-pyrimidinediones
    作者:C. Allen O'Dell、Y. Fulmer Shealy
    DOI:10.1080/15257779408010673
    日期:1994.9
    A new method for obtaining carbocyclic analogues of 3',4'-didehydro-2,4(1H,3H)-pyrimidinedione nucleosides in good yields consists of the reaction of the carbocyclic 2,3'-anhydronucleosides with lithium chloride in dimethylformamide. Small amounts of the carbocyclic 2',3'-didehydro isomers are formed simultaneously. The carbocyclic 2,3'-anhydronucleosides were obtained by treating carbocyclic 5'-trityl derivatives with DAST.
查看更多